Toll‐like receptor 2 (TLR2) and TLR4 differentially activate human mast cells

Sonia Varadaradjalou(Centre National de la Recherche Scientifique), Frédéric Féger(Centre National de la Recherche Scientifique), Nathalie Thiéblemont(Hôpital Necker-Enfants Malades), Nadine Benhamouda(Centre National de la Recherche Scientifique), Jean‐Marie Pléau(Centre National de la Recherche Scientifique), Michel Dy(Hôpital Necker-Enfants Malades), Michel Arock(Centre National de la Recherche Scientifique)
European Journal of Immunology
March 18, 2003
Cited by 290Open Access
Full Text

Abstract

In the present report we have analyzed whether human normal cord blood-derived mast cells (CBMC) could interact with bacterial products, especially lipopolysaccharide (LPS) from Escherichia coli and peptidoglycan (PGN) from Staphylococcus aureus, known as Toll-like receptor (TLR) 4 and TLR2 agonists, respectively. We found that both LPS and PGN induced significant release of not only tumor necrosis factor-alpha (TNF-alpha), but also IL-5, IL-10 and IL-13 by human mast cells (MC). We also established that the stimulation of CBMC with LPS or with PGN is mediated through interactions with TLR4 or with TLR2, respectively. Thus, our data indicate that activation of either TLR2 or TLR4 pathway may lead to a pro-Th2 immune response. However, the release of TNF-alpha induced by LPS, conversely to PGN, required the priming of CBMC by IL-4 and the presence of serum components, in particular soluble CD14. Of interest, stimulation by PGN, but not by LPS, induced release of histamine by human MC. Altogether, these findings provide the first evidence that human MC differentially respond towards bacterial components, and that their responses depend on TLR pathways and reveal human specificities in the pattern of cytokine production.


Related Papers

No related papers found

Powered by citation graph analysis